|
KDM4D expression based on
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.49529999493581E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.00309999999204E-05 |
| Normal-vs-Stage2 |
1.962350E-04 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.736200E-02 |
| Stage1-vs-Stage2 |
6.569000E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.846000E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
9.305800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.95950000459311E-08 |
| Normal-vs-AfricanAmerican |
4.800700E-04 |
| Normal-vs-Asian |
1.50718999999411E-05 |
| Caucasian-vs-AfricanAmerican |
9.630400E-01 |
| Caucasian-vs-Asian |
4.090600E-01 |
| AfricanAmerican-vs-Asian |
3.840600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.020470E-03 |
| Normal-vs-Female |
1.91700000318207E-08 |
| Male-vs-Female |
3.163000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.660600E-03 |
| Normal-vs-Extreme_Weight |
1.73927999999046E-05 |
| Normal-vs-Obese |
1.168150E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
2.318400E-01 |
| Normal_Weight-vs-Obese |
2.349800E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
6.651000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.696820E-01 |
| Normal-vs-Age(41-60Yrs) |
3.336100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.75030000054899E-07 |
| Normal-vs-Age(81-100Yrs) |
4.424000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.527160E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.397410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.234600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.940800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.043400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.752800E-01 |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
3.180400E-02 |
| Normal-vs-Grade 3 |
9.268300E-02 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
4.837000E-01 |
| Grade 2-vs-Grade 4 |
3.180400E-02 |
| Grade 3-vs-Grade 4 |
9.268300E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.08310004987811E-09 |
| Normal-vs-N1 |
3.618000E-02 |
| N0-vs-N1 |
5.244200E-01 |
|
|
